Adjuvant chemotherapy after radical hysterectomy yields comparable outcomes to chemoradiation for stage IB2-IIB and IIIC1-2 cervical cancer: a single-center retrospective study
Radical hysterectomy followed by adjuvant chemotherapy provided RFS outcomes comparable to those achieved with initial chemoradiotherapy for stage IB2-IIB and IIIC1-2 cervical cancer. These findings suggest that both approaches are viable, although further prospective studies are needed.
Authors
- Kenro Chikazawa (ORCID: https://orcid.org/0000-0002-8839-4483)
- Ken Imai (ORCID: https://orcid.org/0000-0002-7593-7960)
- Tomoyuki Kuwata (ORCID: https://orcid.org/0000-0002-9334-6670)
- Ryo Konno (ORCID: https://orcid.org/0000-0002-9403-1339)
- Hiroyoshi Ko (ORCID: https://orcid.org/0009-0004-5009-8963)
Institutions
- Jichi Medical University (JP)
- Jichi Medical University Saitama Medical Center (JP)
Publication Details
- Journal
- Journal of Gynecologic Oncology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.3802/jgo.2025.36.e82
- Citations
- 3
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 6.17
Funders
- AstraZeneca